A five-year study shows that Stereotactic Body Radiation Therapy (SBRT) to treat prostate cancer offers a higher cure rate than more traditional approaches, according to researchers at UT Southwestern Medical Center Harold C. Simmons Comprehensive Cancer Center.
The study – the first trial to publish five-year results from SBRT treatment for prostate cancer – found a 98.6 percent cure rate with SBRT, a noninvasive form of radiation treatment that involves high-dose radiation beams entering the body through various angles and intersecting at the desired target. It is a state-of-the-art technology that allows for a concentrated dose to reach the tumor while limiting the radiation dose to surrounding healthy tissue.
“The high cure rate is striking when compared to the reported five-year cure rates from other approaches like surgery or conventional radiation, which range between 80 to 90 percent, while the side effects of this treatment are comparable to other types of treatment,” said Dr. Raquibul Hannan, Assistant Professor of Radiation Oncology and lead author for the study. “What we now have is a more potent and effective form of completely noninvasive treatment for prostate cancer, conveniently completed in five treatments.”
Conventional treatment options for early stage prostate cancer include:
- Prostatectomy, the surgical removal of the prostate gland, which can be done with minimally invasive techniques and robotic assistance;
- Brachytherapy, in which doctors implant numerous small radioactive seeds about the size of a grain of rice into the prostate gland using multiple large needles inserted through the skin in the operating room. Once implanted, the seeds release their radioactivity directly into the prostate gland; and
- External beam radiation, which involves 42 to 45 treatments administered over two or more months, five days a week.
“The current form of radiation is 44 treatments given over nine weeks. In contrast, the SBRT therapy we used allows the delivery of highly focused radiation in only five treatments, allowing patients to return to their normal lives more quickly,” said senior author Dr. Robert Timmerman, Director of the Annette Simmons Stereotactic Treatment Center at UT Southwestern, and Professor and Vice Chairman of the Department of Radiation Oncology. “SBRT is both more convenient and has increased potency.”
UT Southwestern served as the lead site for the multi-institutional clinical trial, which involved first-time prostate cancer patients diagnosed with stage I or stage II (low and intermediate risk) prostate cancer. A total of 91 patients were treated prospectively and followed for five years, with only one patient experiencing a recurrence of his cancer. The findings are published in the European Journal of Cancer.
Terry Martin of McKinney, Texas, – about an hour outside Dallas – said the fewer number of treatments was a compelling advantage when he was evaluating treatment options.
“I live 45 minutes away from UT Southwestern. The difference between being treated five times versus 44 times is enormous,” said Mr. Martin, a retired airline pilot. “I felt that I was back to normal just 10 days after finishing treatment.”
In addition to shorter treatment times, researchers found that side effects were not necessarily different compared to other forms of prostate cancer treatment. In the short term, the side effects of SBRT can include urinary issues (urgency, frequency and burning) and rectal irritation, which are often temporary and reverse within four weeks of treatment. Researchers found a small risk of longer-term urinary and rectal complications, which is also comparable to conventional treatments. Decrease in erectile function was seen in 25 percent of patients, fewer than with conventional radiation or surgery, said Dr. Hannan.
The Latest on: Stereotactic Body Radiation Therapy
via Google News
The Latest on: Stereotactic Body Radiation Therapy
- Will Accuray Incorporated NASDAQ:ARAY meet your expectations?on August 13, 2019 at 9:17 pm
including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT) and adaptive radiation ...
- Beatson clinical trial gives 'incurable' cancer patients hopeon July 22, 2019 at 4:14 pm
... with a form of high-precision radiotherapy - known as stereotactic ablative radiotherapy (SABR), or stereotactic body radiation therapy (SBRT) - that delivers higher doses of radiation to the area ...
- SBRT Improves Options for Prostate Canceron June 3, 2019 at 5:00 pm
Recently, a new treatment modality for those with a prostate cancer diagnosis, stereotactic body radiation therapy (SBRT), joined the treatment algorithm and is thought to provide improved patient ...
- Stereotactic Body Radiation Therapy (SBRT) to the Cheston December 11, 2018 at 4:00 pm
This information will help you prepare for stereotactic body radiation therapy (SBRT) at Memorial Sloan Kettering (MSK). It will help you know what to expect before, during, and after your treatment.
- Stereotactic body radiation therapy (SBRT) in the management of non-small-cell lung cancer: Clinical impact and patient perspectiveson October 6, 2017 at 5:00 pm
1 Department of Oncology, McMaster University, Hamilton, ON, Canada; 2 Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON, Canada Abstract: Stereotactic body radiation therapy (SBRT) ...
- What Is SBRT?on March 16, 2017 at 6:27 pm
Stereotactic body radiation therapy, or SBRT, is a cancer treatment that delivers extremely precise, very intense doses of radiation to cancer cells while minimizing damage to healthy tissue. SBRT ...
- Stereotactic body radiotherapy treatment of extracranial metastaseson September 24, 2012 at 5:00 pm
Table 1: Suggested dose limits for organs at risk for potential toxicity following stereotactic body radiation therapy * Figure 5: Modern SBRT target localization via CT-image-based alignment of ...
- Stereotactic Body Radiation Therapy for Prostate Canceron November 14, 2011 at 3:11 am
‡ Risk criteria is not available. § Grade 3 or more. ¶ Including IMRT. # Result from nadir+2 is shown in this table. †† n = 101 for toxicity assessment. ‡‡ Once a week over 29 days. §§ Divided into ...
- A Generalized Linear-Quadratic Model for Radiosurgery, Stereotactic Body Radiation Therapy, and High–Dose Rate Brachytherapyon July 6, 2010 at 5:00 pm
1 Department of Radiation Oncology, Ohio State University, Columbus, OH 43210, USA. 2 Department of Radiology, Ohio State University, Columbus, OH 43210, USA. Conventional radiation therapy for cancer ...
- Stereotactic body radiation therapy: a novel treatment modalityon December 7, 2009 at 4:00 pm
Simon S. Lo is Associate Professor of Radiation Oncology and Neurosurgery at Arthur G. James Cancer Hospital, Ohio State University College of Medicine, Columbus, OH USA. , Achilles J. Fakiris 2 ...
via Bing News